Jazz Pharma is breaking new ground with its cannabidiol epilepsy treatment Epidiolex, taking the drug into a Phase III study in children and adolescents.
https://www.pharmalive.com/wp-content/uploads/2021/07/Jazz-Pharmaceuticals-Wins-FDA-Nod-for-New-ALL-and-LBL-Drug-BioSpace-7-1-21-1.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-08-18 11:26:232022-08-18 11:26:23Jazz takes groundbreaking epilepsy drug into kids in Phase III trial
